Hemophilia B

This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in June and July, including the first over-the-counter, nonprescription daily oral contraceptive, the first monoclonal...

This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in June and July, including the first over-the-counter, nonprescription daily oral contraceptive, the first monoclonal...

The FDA has approved new options for basal cell carcinoma, HIV diagnosis, and high cholesterol that clinicians should be aware of.

The FDA has approved new options for major depressive disorder, schizophrenia, and metastatic non-small cell lung cancer, that clinicians should be aware of.

The FDA has decided to strengthen existing cardiovascular warnings on the labels of prescription non-aspirin nonsteroidal anti-inflammatory drugs.

The FDA has approved new options for the treatment of heart failure and cystic fibrosis, and issued a warning on unapproved prescription ear drops.

The FDA has approved new options for the treatment of heart failure and cystic fibrosis, and issued a warning on unapproved prescription ear drops.

The FDA has approved new options for the treatment of heart failure and cystic fibrosis, and issued a warning on unapproved prescription ear drops.

The FDA finalized a decision determining that partially hydrogenated oils were not generally recognized as safe.

The FDA finalized a decision determining that partially hydrogenated oils were not generally recognized as safe.